← FDA Drug Approvals (Drugs@FDA)
NALOXONE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BPI LABS · Approved 2023-10-06
Drug application
- FDA Application #
ANDA216977- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NALOXONE HYDROCHLORIDE
- Generic name
- NALOXONE HYDROCHLORIDE
- Active ingredients
- NALOXONE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- BPI LABS
- Manufacturer
- BPI Labs LLC
- First approval
- 2023-10-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown